In MR phenome-wide association studies, we found that plasma MAPK3 levels could reduce the risk of RA, while higher plasma ITIH1 levels might increase the risk of bipolar and reduce the risk of chronic ischemic heart disease. The gene discussed is ITIH1; the disease is rheumatoid arthritis.